Compare GRFS & COMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | COMP |
|---|---|---|
| Founded | 1940 | 2012 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.8B |
| IPO Year | N/A | 2021 |
| Metric | GRFS | COMP |
|---|---|---|
| Price | $7.62 | $7.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | $10.15 | ★ $12.36 |
| AVG Volume (30 Days) | 818.8K | ★ 14.2M |
| Earning Date | 07-28-2022 | 05-07-2026 |
| Dividend Yield | ★ 1.85% | N/A |
| EPS Growth | N/A | ★ 67.74 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,961,600,000.00 |
| Revenue This Year | $5.33 | $78.80 |
| Revenue Next Year | $6.50 | $9.22 |
| P/E Ratio | $18.67 | ★ N/A |
| Revenue Growth | N/A | ★ 23.67 |
| 52 Week Low | $6.19 | $5.66 |
| 52 Week High | $11.14 | $13.96 |
| Indicator | GRFS | COMP |
|---|---|---|
| Relative Strength Index (RSI) | 32.80 | 34.40 |
| Support Level | N/A | $7.14 |
| Resistance Level | $9.11 | $8.30 |
| Average True Range (ATR) | 0.21 | 0.44 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 17.39 | 0.00 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.